Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators

Background. Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Yin, Pranke, Stephanie, Rashidi, Farid, Nosib, Shravan, Worobetz, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350419/
https://www.ncbi.nlm.nih.gov/pubmed/28349045
http://dx.doi.org/10.1155/2017/7298032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350419/
https://www.ncbi.nlm.nih.gov/pubmed/28349045
http://dx.doi.org/10.1155/2017/7298032

Ejemplares similares